This site is intended for healthcare professionals
Drug news

Positive results from study of STX 209 (Seaside Therapeutics) for patients with Fragile X Syndrome

Read time: 1 mins
Last updated:21st Sep 2012
Published:21st Sep 2012
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest